GO:1990660 calprotectin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990660 calprotectin complex is a heterodimer of S100A8 and S100A9 that limits Mn2+ and Zn2+ availability at infection sites and binds Ca2+.
• It is expressed and released mainly by neutrophils and epithelial cells and acts as an endogenous ligand of TLR4 and RAGE, initiating NF-kappa-B signaling.
• Calprotectin is a broad-spectrum antimicrobial protein whose activity is attributed to its metal-chelating properties.
• Fecal calprotectin is a widely used non-invasive biomarker of intestinal inflammation and is reviewed for colorectal cancer and inflammatory bowel disease.
• Calprotectin is also studied in rheumatic diseases such as spondyloarthritis and psoriatic arthritis, where it reflects innate immune activation.
• Comparative studies show that zebrafish lack a calprotectin ortholog, highlighting evolutionary differences in S100A8/S100A9 biology.
Description
The calprotectin complex (GO:1990660) is a calcium-binding heterodimer of the S100 proteins S100A8 and S100A9 that is released by neutrophils and epithelial cells and functions as a metal-sequestering antimicrobial agent. Its ability to limit Mn2+ and Zn2+ availability at sites of infection gives it broad-spectrum antimicrobial activity, while its capacity to bind Ca2+ links it to calcium-dependent signaling and inflammatory responses. Beyond host defense, calprotectin is an endogenous ligand of toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE), initiating signal transduction through NF-kappa-B pathways. This dual role as a metal-binding effector and a danger-associated molecular pattern makes it a central node in innate immunity and inflammation. Researchers study GO:1990660 because it bridges metal homeostasis, antimicrobial defense, and inflammatory signaling, and because its abundance in stool and serum makes it a practical biomarker for several diseases. Fecal calprotectin is routinely used to distinguish inflammatory bowel disease from functional gastrointestinal disorders, and it is being evaluated in colorectal cancer and rheumatic conditions. The complex is also of interest in comparative biology, as some model organisms such as zebrafish do not have a calprotectin ortholog, which affects how inflammation models are interpreted.
calprotectin complex At A Glance
| GO ID | GO:1990660 |
|---|---|
| GO term | calprotectin complex |
| Ontology | cellular_component |
| Synonym | calprotectin heterodimer |
| Major function | Limits Mn2+ and Zn2+ availability at infection sites; binds Ca2+; broad-spectrum antimicrobial activity; endogenous ligand of TLR4 and RAGE initiating NF-kappa-B signaling |
| Subunits | S100A8 and S100A9 |
| Expressed by | Neutrophils and epithelial cells |
| Metal-binding properties | Mn2+, Zn2+, Ca2+ |
| Signaling receptors | TLR4 and RAGE |
| Downstream pathway | NF-kappa-B |
What Is GO:1990660?
According to the Gene Ontology, GO:1990660 calprotectin complex is a protein complex composed of S100A8 and S100A9 that is capable of limiting Mn2+ and Zn2+ availability at sites of infection and also binds Ca2+. It is expressed and released by neutrophils and epithelial cells and exhibits broad-spectrum antimicrobial activity attributed to its metal-binding properties. It acts as an endogenous ligand of TLR4 and RAGE, initiating signal transduction through NF-kappa-B pathways. The synonym calprotectin heterodimer reflects its two-subunit composition.
Why Is calprotectin complex Important in Cell Biology?
GO:1990660 calprotectin complex is important because it integrates metal restriction, antimicrobial defense, and innate immune signaling in a single molecular entity. Its metal-chelating activity directly starves pathogens of essential manganese and zinc, while its engagement of TLR4 and RAGE amplifies inflammatory NF-kappa-B responses. Clinically, calprotectin is one of the most widely used non-invasive biomarkers of intestinal inflammation, and it is increasingly studied in colorectal cancer, spondyloarthritis, and psoriatic arthritis. Understanding its assembly, regulation, and downstream effects is therefore relevant to infectious disease, gastroenterology, rheumatology, and oncology research.
• Provides broad-spectrum antimicrobial activity by limiting Mn2+ and Zn2+ availability at infection sites.
• Acts as an endogenous ligand of TLR4 and RAGE, initiating NF-kappa-B signal transduction.
• Serves as a non-invasive fecal biomarker for intestinal inflammation and inflammatory bowel disease.
• Is evaluated as a biomarker in colorectal cancer, with systematic review evidence supporting its potential.
• Is implicated in spondyloarthritis and other rheumatic diseases as a marker of innate immune activation.
• Is studied in psoriatic arthritis, where it reflects inflammation and possibly additional disease processes.
• Binds Ca2+, linking its function to calcium-dependent cellular responses.
• Shows evolutionary divergence, as zebrafish do not have a calprotectin ortholog, affecting comparative models.
• Is released by neutrophils and epithelial cells, positioning it at the interface of innate immunity and mucosal defense.
• Its heterodimeric S100A8/S100A9 structure is a target for structural and interaction studies.
Structure and Composition of calprotectin complex
S100A8 and S100A9 heterodimerization
In simple terms: Two different proteins, S100A8 and S100A9, join together to form the calprotectin complex.
The calprotectin complex is a heterodimer composed of S100A8 and S100A9 subunits. This non-covalent association creates the functional unit that is released by neutrophils and epithelial cells and that carries the metal-binding and receptor-ligand activities described for GO:1990660. The heterodimer is often referred to as calprotectin heterodimer, reflecting its two-subunit composition.
Calcium-binding and metal-chelating sites
In simple terms: The complex can hold calcium and also grab manganese and zinc, which helps it fight microbes.
Calprotectin binds Ca2+ and is capable of limiting Mn2+ and Zn2+ availability at sites of infection. These metal-binding properties are attributed to the S100A8/S100A9 heterodimer and underlie its broad-spectrum antimicrobial activity. The ability to sequester essential transition metals is a key functional feature of the complex in host defense.
Expression and release by neutrophils and epithelial cells
In simple terms: Immune cells and lining cells produce and release calprotectin.
The calprotectin complex is expressed and released by neutrophils and epithelial cells. This cellular distribution places it at mucosal surfaces and in inflamed tissues, where it can act on pathogens and on host receptors. Its release is associated with inflammatory conditions, which is why it is measured in stool and serum as a biomarker.
Receptor engagement and NF-kappa-B signaling
In simple terms: Calprotectin can bind to receptors on cells and switch on inflammatory signals.
Calprotectin is an endogenous ligand of toll-like receptor 4 (TLR4) and of the receptor for advanced glycation end products (RAGE), initiating signal transduction through NF-kappa-B pathways. This receptor engagement links the metal-binding complex to innate immune activation and inflammatory gene expression. The dual receptor usage broadens the contexts in which GO:1990660 can influence cell behavior.
Antimicrobial effector function
In simple terms: By starving microbes of metals, calprotectin helps kill or inhibit them.
The broad-spectrum antimicrobial activity of the calprotectin complex is attributed to its metal-binding properties, particularly its ability to limit Mn2+ and Zn2+ availability. This nutritional immunity mechanism is a central function of the complex at sites of infection. The same properties that restrict microbial growth also contribute to its role as an inflammatory mediator.
Key Genes Involved in GO:1990660 calprotectin complex
The following genes and proteins are directly or functionally associated with the calprotectin complex (GO:1990660) and its biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| S100A8 | Subunit of the calprotectin heterodimer; contributes to metal binding and antimicrobial activity | Core component of GO:1990660; target for knockout and structural studies |
| S100A9 | Subunit of the calprotectin heterodimer; required for complex formation and function | Core component of GO:1990660; target for knockout and interaction studies |
| TLR4 | Receptor for calprotectin; initiates NF-kappa-B signaling | Mediates inflammatory signaling by the complex |
| RAGE | Receptor for calprotectin; initiates NF-kappa-B signaling | Mediates inflammatory signaling by the complex |
| NFKB1 | Transcription factor downstream of TLR4/RAGE | Readout of calprotectin-induced signaling |
| NFKB2 | Transcription factor downstream of TLR4/RAGE | Readout of calprotectin-induced signaling |
| RELA | NF-kappa-B subunit activated downstream of TLR4/RAGE | Readout of calprotectin-induced signaling |
| IL6 | Cytokine induced by NF-kappa-B | Inflammatory output associated with calprotectin activity |
| TNF | Cytokine induced by NF-kappa-B | Inflammatory output associated with calprotectin activity |
| IL1B | Cytokine induced by NF-kappa-B | Inflammatory output associated with calprotectin activity |
| CXCL8 | Chemokine induced by NF-kappa-B | Neutrophil recruitment readout in calprotectin studies |
| MPO | Neutrophil granule protein co-released with calprotectin | Marker of neutrophil activation in inflammation |
| ELANE | Neutrophil serine protease co-released with calprotectin | Marker of neutrophil activation in inflammation |
| ITGAM | Integrin involved in neutrophil adhesion and activation | Context for calprotectin release |
| ITGB2 | Integrin involved in neutrophil adhesion and activation | Context for calprotectin release |
| CD14 | Co-receptor for TLR4 | Modulates calprotectin-TLR4 signaling |
| LY96 | MD-2 co-receptor for TLR4 | Modulates calprotectin-TLR4 signaling |
| AGER | Gene encoding RAGE | Receptor for calprotectin |
How Is calprotectin complex Regulated?
The expression and release of the calprotectin complex are associated with inflammatory activation of neutrophils and epithelial cells. Its function is regulated at the level of metal availability, since Ca2+, Mn2+, and Zn2+ binding modulate its antimicrobial and signaling activities. Downstream, calprotectin-initiated signals through TLR4 and RAGE converge on NF-kappa-B pathways, which can further amplify inflammatory gene expression. In clinical settings, calprotectin levels are used as a dynamic marker of inflammation, reflecting its regulated release during disease activity.
calprotectin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| S100A8/S100A9 | Inflammatory bowel disease; intestinal inflammation | Knockout or knock-in models in intestinal epithelial cells and neutrophils |
| S100A8/S100A9 | Colorectal cancer | Overexpression and knockout in colorectal cancer cell lines |
| S100A8/S100A9 | Spondyloarthritis and psoriatic arthritis | Point-mutation and knockout models in immune cells |
| TLR4 | Calprotectin-induced NF-kappa-B signaling | Knockout and point-mutation models in macrophages |
| RAGE | Calprotectin-induced NF-kappa-B signaling | Knockout and point-mutation models in epithelial and immune cells |
Calprotectin in inflammatory bowel disease and intestinal inflammation
Fecal calprotectin is a well-established non-invasive biomarker for intestinal inflammation and is widely used to distinguish inflammatory bowel disease from functional gastrointestinal disorders. Its stability in stool and its direct reflection of neutrophil influx into the gut mucosa make it a practical tool for monitoring disease activity. The metal-binding and antimicrobial properties of the complex are thought to contribute to mucosal defense, while its release also marks pathological inflammation.
Calprotectin in colorectal cancer
A systematic review has evaluated the value of the calprotectin S100A8/A9 complex as a biomarker in colorectal cancer. Elevated calprotectin levels in stool or serum have been associated with colorectal cancer in multiple studies, supporting its potential as a diagnostic or monitoring marker. The complex may also influence tumor microenvironment inflammation through its receptor-mediated signaling.
Calprotectin in rheumatic diseases
Calprotectin is studied in rheumatic diseases, including spondyloarthritis and psoriatic arthritis, where it reflects innate immune activation and inflammation. In spondyloarthritis, calprotectin has been discussed as a potential biomarker of disease activity. In psoriatic arthritis, it is considered a marker of inflammation and possibly of additional disease processes beyond joint inflammation. These findings link GO:1990660 to chronic inflammatory joint disease.
Evolutionary and comparative considerations
Comparative studies show that zebrafish do not have a calprotectin ortholog, which is important when interpreting inflammation models in this organism. This absence highlights that S100A8/S100A9-based calprotectin biology is not universally conserved and that model organism choice matters for studying GO:1990660. Researchers using zebrafish should account for this difference when translating findings to human inflammatory diseases.
From calprotectin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of S100A8/S100A9 abolish calprotectin complex formation and antimicrobial activity? | S100A8 or S100A9 knockout cell lines |
| Which residues mediate Mn2+ and Zn2+ binding? | Point-mutation knock-in of metal-coordinating residues |
| How does calprotectin engagement of TLR4 activate NF-kappa-B? | TLR4 knockout and tagged knock-in reporter cells |
| Does calprotectin-RAGE signaling contribute to inflammatory gene expression? | RAGE knockout and overexpression models |
| Can calprotectin serve as a biomarker in colorectal cancer models? | Overexpression and knockout in colorectal cancer cell lines |
| How does calprotectin release affect neutrophil-epithelial interactions? | Co-culture models with tagged knock-in S100A8/S100A9 |
How to Study the calprotectin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fecal calprotectin assay | Calprotectin concentration in stool | Diagnosis and monitoring of intestinal inflammation |
| Serum calprotectin ELISA | Circulating calprotectin levels | Assessment of systemic inflammation in rheumatic diseases |
| Immunoblotting | S100A8/S100A9 protein expression and heterodimer formation | Basic characterization of the complex |
| Metal-binding assays | Mn2+ and Zn2+ chelation capacity | Functional studies of antimicrobial activity |
| NF-kappa-B reporter assays | TLR4/RAGE-dependent signaling | Mechanistic studies of calprotectin-induced inflammation |
| Cytokine profiling | IL6, TNF, IL1B, CXCL8 production | Downstream readout of calprotectin signaling |
| Immunofluorescence | Cellular localization and release of calprotectin | Neutrophil and epithelial cell studies |
| CRISPR knockout screens | Genes required for calprotectin function or signaling | Discovery of modifiers of GO:1990660 biology |
Biomarker quantification in stool and serum
Calprotectin is routinely measured in stool and serum as a biomarker of inflammation, with fecal calprotectin being the most established application. These assays are used to distinguish inflammatory bowel disease from functional disorders and to monitor disease activity. In colorectal cancer research, calprotectin levels have been evaluated as potential diagnostic markers.
Proteomic and biochemical analysis of the heterodimer
Biochemical and proteomic methods can characterize the S100A8/S100A9 heterodimer, its metal-binding properties, and its interactions with TLR4 and RAGE. These approaches help define the structural basis of GO:1990660 function. Metal-binding assays specifically address the Mn2+ and Zn2+ chelation that underlies antimicrobial activity.
Cell-based signaling assays
Cell-based assays using macrophages, neutrophils, or epithelial cells can measure NF-kappa-B activation and cytokine production after calprotectin stimulation. Knockout or knockdown of TLR4 and RAGE helps attribute signaling to specific receptors. Such experiments link the complex to inflammatory gene expression programs.
Imaging and localization studies
Imaging approaches can visualize calprotectin release from neutrophils and epithelial cells and its localization at sites of infection or inflammation. Tagged knock-in models enable tracking of S100A8/S100A9 in live cells. These methods complement biochemical and biomarker studies of GO:1990660.
How CRISPR Can Be Used to Study GO:1990660 calprotectin complex
Knockout
CRISPR knockout of S100A8 or S100A9 can abolish calprotectin complex formation and is used to test its antimicrobial and signaling functions. Knockout of TLR4 or RAGE helps determine which receptor mediates NF-kappa-B activation by calprotectin. These models are foundational for causal studies of GO:1990660.
Point Mutation
Point mutations can be introduced into S100A8 or S100A9 to dissect metal-coordinating residues required for Mn2+ and Zn2+ binding. Such mutants help separate the antimicrobial activity of the complex from its receptor-mediated signaling. Point mutations in TLR4 or RAGE can similarly map signaling interfaces.
Knock-in
Knock-in of tagged S100A8 or S100A9 allows tracking of the calprotectin complex in cells and tissues. Reporter knock-ins can monitor NF-kappa-B activation downstream of TLR4 and RAGE. These models are valuable for studying release, localization, and signaling in physiologically relevant contexts.
Overexpression
Overexpression of S100A8 and S100A9 can drive calprotectin complex formation and is used to study its effects on inflammation and cell behavior. Overexpression models also help evaluate calprotectin as a biomarker or effector in cancer and rheumatic disease research. Combining overexpression with receptor knockout clarifies downstream pathways.
How EDITGENE Supports calprotectin complex Research
Researchers studying calprotectin complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, metal binding, or receptor-mediated signaling. EDITGENE provides CRISPR-based cell model services that enable such causal experiments in relevant immune and epithelial cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for calprotectin complex research.
Frequently Asked Questions About calprotectin complex
What is calprotectin complex?
Calprotectin complex (GO:1990660) is a heterodimer of S100A8 and S100A9 that limits Mn2+ and Zn2+ availability at infection sites, binds Ca2+, and acts as an antimicrobial and inflammatory mediator.
What genes are involved in calprotectin complex?
The core genes are S100A8 and S100A9, while TLR4 and RAGE encode receptors that mediate its NF-kappa-B signaling.
What is the function of GO:1990660?
GO:1990660 functions in metal sequestration, broad-spectrum antimicrobial defense, and TLR4/RAGE-mediated NF-kappa-B signaling.
Where is calprotectin complex expressed?
It is expressed and released by neutrophils and epithelial cells.
What is fecal calprotectin used for?
Fecal calprotectin is used as a non-invasive biomarker of intestinal inflammation and to distinguish inflammatory bowel disease from functional disorders.
Is calprotectin a biomarker for colorectal cancer?
A systematic review has evaluated the S100A8/A9 complex as a biomarker in colorectal cancer, supporting its potential but requiring further validation.
How is calprotectin related to rheumatic diseases?
Calprotectin is studied in spondyloarthritis and psoriatic arthritis as a marker of innate immune activation and inflammation.
Does zebrafish have calprotectin?
No, zebrafish do not have a calprotectin ortholog, which is important for comparative inflammation studies.
What receptors does calprotectin bind?
Calprotectin is an endogenous ligand of TLR4 and RAGE, initiating NF-kappa-B signaling.
How can CRISPR be used to study calprotectin complex?
CRISPR knockout, point mutation, knock-in, and overexpression models can test the roles of S100A8, S100A9, TLR4, and RAGE in calprotectin biology.
Conclusion
GO:1990660 calprotectin complex is a multifunctional S100A8/S100A9 heterodimer that couples metal restriction to antimicrobial defense and inflammatory signaling through TLR4 and RAGE. Its clinical relevance spans intestinal inflammation, colorectal cancer, and rheumatic diseases, where it serves as a practical biomarker and a potential therapeutic target. Continued research using CRISPR-based models will help clarify the causal contributions of the complex and its receptors in human disease.
References
- 1. Ayling RM et al.. 2018. Fecal Calprotectin.. Adv Clin Chem 87:161-190 PMID: 30342711
- 2. Yui S et al.. 2003. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity.. Biol Pharm Bull 26(6):753-60 PMID: 12808281
- 3. Moris D et al.. 2016. The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.. J BUON 21(4):859-866 PMID: 27685906
- 4. Wendling D et al.. 2017. Calprotectin and spondyloarthritis.. Expert Rev Clin Immunol 13(4):295-296 PMID: 28110580
- 5. Ometto F et al.. 2017. Calprotectin in rheumatic diseases.. Exp Biol Med (Maywood) 242(8):859-873 PMID: 27895095
- 6. Huang JX et al.. 2023. Calprotectin in psoriatic arthritis: Inflammation and beyond.. Int J Rheum Dis 26(1):11-12 PMID: 36591902
- 7. Orlandi KN et al.. 2025. Zebrafish do not have a calprotectin ortholog.. PLoS One 20(5):e0322649 PMID: 40315184
- 8. Rodrigo L. 2007. [Fecal calprotectin].. Rev Esp Enferm Dig 99(12):683-8 PMID: 18290690
